Trademark: 79139166
Status Date
Tuesday, August 8, 2023
Registration Number
4500109
Registration Date
Tuesday, March 25, 2014
Filing Date
Friday, August 9, 2013
Published for Opposition
Tuesday, January 7, 2014
Cancellation Date
Wednesday, August 9, 2023
5 Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII
Mar 3, 2024
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Mar 3, 2024
Death Of International Registration
Apr 17, 2022
Total Invalidation Processed By The Ib
Mar 10, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Mar 10, 2022
Invalidation Processed
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
Aug 18, 2016
New Representative At Ib Received
Aug 11, 2016
New Representative At Ib Received
Aug 11, 2016
New Representative At Ib Received
Jul 4, 2014
Notification Processed By Ib
Jun 16, 2014
Final Disposition Notice Sent To Ib
Jun 16, 2014
Final Disposition Processed
Apr 24, 2014
Grant Of Protection Created, To Be Sent To Ib
Mar 25, 2014
Registered-Principal Register
Mar 7, 2014
Notification Processed By Ib
Jan 7, 2014
Published For Opposition
Jan 3, 2014
New Representative At Ib Received
Dec 18, 2013
Notification Of Possible Opposition Sent To Ib
Dec 18, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 18, 2013
Notice Of Publication
Dec 7, 2013
Application Filing Receipt Mailed
Dec 5, 2013
Approved For Pub - Principal Register
Dec 3, 2013
Assigned To Examiner
Dec 3, 2013
New Application Office Supplied Data Entered
Nov 28, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
